US Patent 9068199 Therapeutic retroviral vectors for gene therapy
All edits
Edits on 9 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+482 characters)
Article
Patent abstract
The invention provides improved compositions and methods for achieving gene therapy in hematopoietic cells and hematopoietic precursor cells, including erythrocytes, erythroid progenitors, and embryonic stem cells. The invention further provides improved gene therapy methods for treating hematopoietic-related disorders. Retroviral gene therapy vectors that are optimized for erythroid specific expression and treatment of hemoglobinopathic conditions are disclosed.
Edits on 28 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Karen Westerman0
Philippe Leboulch0
Robert Pawliuk0
Edits on 21 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09068199 Therapeutic retroviral vectors for gene therapy US Patent 9068199 Therapeutic retroviral vectors for gene therapy
Infobox
Patent Number
09068199
Patent Number
9068199
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Jan, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 09068199 Therapeutic retroviral vectors for gene therapy
Infobox
Is a
Patent jurisdiction
Patent number
09068199
Date of patent
June 30, 2015
Patent application number
13242815
Date Filed
September 23, 2011
Patent primary examiner
Find more entities like US Patent 9068199 Therapeutic retroviral vectors for gene therapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.